Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?

During SARS-CoV-2 pandemic, we adopted a personalized delayed protocol for ocrelizumab infusions in Relapsing Remitting Multiple Sclerosis (RRMS) patients according to the national recommendations. Out of the 83 RRMS patients whose infusion was scheduled between March and December 2020, 56 patients...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Neurol Sci
Main Authors: Tazza, F., Lapucci, C., Cellerino, M., Boffa, G., Novi, G., Poire, I., Mancuso, E., Bruschi, N., Sbragia, E., Laroni, A., Capello, E., Inglese, M.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier B.V. 2021
Fag:
Clinical Short Communication
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8133824/
https://ncbi.nlm.nih.gov/pubmed/34044238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2021.117501
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker